Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample

Randy Neblett, Meredith M. Hartzell, Howard Cohen, Tom G. Mayer, Mark Williams, Yun Hee Choi, Robert Joseph Gatchel

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Objectives: The aim of this study was to determine the ability of the central sensitization inventory (CSI), a new screening instrument, to assist clinicians in identifying patients with central sensitivity syndromes (CSSs). Methods: Patients from a psychiatric medical practice (N=161), which specialized in the assessment and treatment of complex pain and psychophysiological disorders, were assessed for the presence of a CSS. CSI scores, using a previously determined cutoff of "40"of "100," were compared between the CSS patient group (n=99) and the non-CSS patient group (n=62). Information on false positives, false negatives, true positives, and true negatives were analyzed, and sensitivity and specificity analyses were conducted. In addition, CSS-relevant variables such as depression, abuse, and substance abuse were examined. Results: A large percentage of CSS patients had comorbid major depressive disorder (80%) and abuse history (43%), which was higher than rates for the patients without a CSS (55% and 24%, respectively). The CSI correctly identified 82.8% (n=82) of CSS patients as having a CSS (ie, sensitivity) and 54.8% (n=28) of non-CSS patients as not having a CSS (ie, specificity). False-positive patients (not diagnosed with a CSS, but scoring >40 on the CSI) reported more severe pain, interference in daily functioning, and abuse history, compared with the non-CSS patients who scored below 40 (ie, true negatives). Conclusions: The CSI is a useful and valid instrument for screening patients for the possibility of a CSS, although the chances of false positives are relatively high when evaluating patients with complex pain and psychophysiological disorders.

Original languageEnglish
Pages (from-to)323-332
Number of pages10
JournalClinical Journal of Pain
Volume31
Issue number4
DOIs
StatePublished - 27 Mar 2015

Fingerprint

Central Nervous System Sensitization
Aptitude
Chronic Pain
Outpatients
Equipment and Supplies
Psychophysiologic Disorders
Somatoform Disorders
Major Depressive Disorder

Keywords

  • Central sensitivity syndrome
  • Central sensitization
  • Central sensitization inventory
  • Chronic widespread pain
  • Fibromyalgia

Cite this

Neblett, Randy ; Hartzell, Meredith M. ; Cohen, Howard ; Mayer, Tom G. ; Williams, Mark ; Choi, Yun Hee ; Gatchel, Robert Joseph. / Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. In: Clinical Journal of Pain. 2015 ; Vol. 31, No. 4. pp. 323-332.
@article{9fbe2cc0748347cfa063b195311f8a4c,
title = "Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample",
abstract = "Objectives: The aim of this study was to determine the ability of the central sensitization inventory (CSI), a new screening instrument, to assist clinicians in identifying patients with central sensitivity syndromes (CSSs). Methods: Patients from a psychiatric medical practice (N=161), which specialized in the assessment and treatment of complex pain and psychophysiological disorders, were assessed for the presence of a CSS. CSI scores, using a previously determined cutoff of {"}40{"}of {"}100,{"} were compared between the CSS patient group (n=99) and the non-CSS patient group (n=62). Information on false positives, false negatives, true positives, and true negatives were analyzed, and sensitivity and specificity analyses were conducted. In addition, CSS-relevant variables such as depression, abuse, and substance abuse were examined. Results: A large percentage of CSS patients had comorbid major depressive disorder (80{\%}) and abuse history (43{\%}), which was higher than rates for the patients without a CSS (55{\%} and 24{\%}, respectively). The CSI correctly identified 82.8{\%} (n=82) of CSS patients as having a CSS (ie, sensitivity) and 54.8{\%} (n=28) of non-CSS patients as not having a CSS (ie, specificity). False-positive patients (not diagnosed with a CSS, but scoring >40 on the CSI) reported more severe pain, interference in daily functioning, and abuse history, compared with the non-CSS patients who scored below 40 (ie, true negatives). Conclusions: The CSI is a useful and valid instrument for screening patients for the possibility of a CSS, although the chances of false positives are relatively high when evaluating patients with complex pain and psychophysiological disorders.",
keywords = "Central sensitivity syndrome, Central sensitization, Central sensitization inventory, Chronic widespread pain, Fibromyalgia",
author = "Randy Neblett and Hartzell, {Meredith M.} and Howard Cohen and Mayer, {Tom G.} and Mark Williams and Choi, {Yun Hee} and Gatchel, {Robert Joseph}",
year = "2015",
month = "3",
day = "27",
doi = "10.1097/AJP.0000000000000113",
language = "English",
volume = "31",
pages = "323--332",
journal = "Clinical Journal of Pain",
issn = "0749-8047",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "4",

}

Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. / Neblett, Randy; Hartzell, Meredith M.; Cohen, Howard; Mayer, Tom G.; Williams, Mark; Choi, Yun Hee; Gatchel, Robert Joseph.

In: Clinical Journal of Pain, Vol. 31, No. 4, 27.03.2015, p. 323-332.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample

AU - Neblett, Randy

AU - Hartzell, Meredith M.

AU - Cohen, Howard

AU - Mayer, Tom G.

AU - Williams, Mark

AU - Choi, Yun Hee

AU - Gatchel, Robert Joseph

PY - 2015/3/27

Y1 - 2015/3/27

N2 - Objectives: The aim of this study was to determine the ability of the central sensitization inventory (CSI), a new screening instrument, to assist clinicians in identifying patients with central sensitivity syndromes (CSSs). Methods: Patients from a psychiatric medical practice (N=161), which specialized in the assessment and treatment of complex pain and psychophysiological disorders, were assessed for the presence of a CSS. CSI scores, using a previously determined cutoff of "40"of "100," were compared between the CSS patient group (n=99) and the non-CSS patient group (n=62). Information on false positives, false negatives, true positives, and true negatives were analyzed, and sensitivity and specificity analyses were conducted. In addition, CSS-relevant variables such as depression, abuse, and substance abuse were examined. Results: A large percentage of CSS patients had comorbid major depressive disorder (80%) and abuse history (43%), which was higher than rates for the patients without a CSS (55% and 24%, respectively). The CSI correctly identified 82.8% (n=82) of CSS patients as having a CSS (ie, sensitivity) and 54.8% (n=28) of non-CSS patients as not having a CSS (ie, specificity). False-positive patients (not diagnosed with a CSS, but scoring >40 on the CSI) reported more severe pain, interference in daily functioning, and abuse history, compared with the non-CSS patients who scored below 40 (ie, true negatives). Conclusions: The CSI is a useful and valid instrument for screening patients for the possibility of a CSS, although the chances of false positives are relatively high when evaluating patients with complex pain and psychophysiological disorders.

AB - Objectives: The aim of this study was to determine the ability of the central sensitization inventory (CSI), a new screening instrument, to assist clinicians in identifying patients with central sensitivity syndromes (CSSs). Methods: Patients from a psychiatric medical practice (N=161), which specialized in the assessment and treatment of complex pain and psychophysiological disorders, were assessed for the presence of a CSS. CSI scores, using a previously determined cutoff of "40"of "100," were compared between the CSS patient group (n=99) and the non-CSS patient group (n=62). Information on false positives, false negatives, true positives, and true negatives were analyzed, and sensitivity and specificity analyses were conducted. In addition, CSS-relevant variables such as depression, abuse, and substance abuse were examined. Results: A large percentage of CSS patients had comorbid major depressive disorder (80%) and abuse history (43%), which was higher than rates for the patients without a CSS (55% and 24%, respectively). The CSI correctly identified 82.8% (n=82) of CSS patients as having a CSS (ie, sensitivity) and 54.8% (n=28) of non-CSS patients as not having a CSS (ie, specificity). False-positive patients (not diagnosed with a CSS, but scoring >40 on the CSI) reported more severe pain, interference in daily functioning, and abuse history, compared with the non-CSS patients who scored below 40 (ie, true negatives). Conclusions: The CSI is a useful and valid instrument for screening patients for the possibility of a CSS, although the chances of false positives are relatively high when evaluating patients with complex pain and psychophysiological disorders.

KW - Central sensitivity syndrome

KW - Central sensitization

KW - Central sensitization inventory

KW - Chronic widespread pain

KW - Fibromyalgia

UR - http://www.scopus.com/inward/record.url?scp=84925877205&partnerID=8YFLogxK

U2 - 10.1097/AJP.0000000000000113

DO - 10.1097/AJP.0000000000000113

M3 - Article

C2 - 24806467

AN - SCOPUS:84925877205

VL - 31

SP - 323

EP - 332

JO - Clinical Journal of Pain

JF - Clinical Journal of Pain

SN - 0749-8047

IS - 4

ER -